Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
AL ›
ALEMBIC PHARMACEUTICALS
Trademark search for:
ALEMBIC PHARMACEUTICALS
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-10-18 — Application filed
2019-10-22 — Application filed
2020-01-24 — Assigned to examiner
2020-01-27 — Final disposition recorded
2020-01-27 — Final disposition recorded
2020-01-27 — Final disposition recorded
2020-03-27 — Office action issued
2020-03-27 — Correspondence received in law office
2020-03-28 — Teas/email correspondence entered
2020-04-21 — Office action issued
2020-04-21 — Office action issued
2020-04-21 — Office action issued
2020-07-01 — Teas request for reconsideration received
2020-07-01 — Exparte appeal received at ttab
2020-07-01 — Jurisdiction restored to examining attorney
2020-07-01 — Ex parte appeal-instituted
2020-07-12 — Assigned to lie
2020-07-14 — Teas/email correspondence entered
2020-07-14 — Correspondence received in law office
2020-07-30 — Final disposition recorded
2020-07-30 — Final disposition recorded
2020-07-30 — Final disposition recorded
2020-12-01 — Teas/email correspondence entered
2020-12-01 — Office action issued
2020-12-01 — Correspondence received in law office
2021-01-06 — Office action issued
2021-01-06 — Final disposition recorded
2021-01-06 — Final disposition recorded
2021-03-24 — Teas request for reconsideration received
2021-03-26 — Jurisdiction restored to examining attorney
2021-05-17 — Jurisdiction restored to examining attorney
2021-06-17 — Final disposition recorded
2021-06-17 — Examiners amendment -written
2021-06-17 — Notification of action denying req for recon e-mailed
2021-06-17 — Action denying req for recon e-mailed
2021-06-17 — Examiners amendment e-mailed
2021-06-17 — Notification of examiners amendment e-mailed
2021-06-17 — Examiner's amendment entered
2021-09-08 — Jurisdiction restored to examining attorney
2021-10-27 — Examiners request for remand to ttab
2021-11-02 — Jurisdiction restored to examining attorney
2021-12-08 — Office action issued
2021-12-08 — Notification of action denying req for recon e-mailed
2021-12-08 — Action denying req for recon e-mailed
2022-03-28 — Jurisdiction restored to examining attorney
2022-05-25 — Examiners statement - completed
2022-05-25 — Notification of examiners statement e-mailed
2022-05-25 — Examiners statement e-mailed
2022-06-29 — Reply brief filed - check ttab files
2022-09-13 — Office action issued
2022-11-28 — Application abandoned
2022-11-28 — Exparte appeal terminated
2022-11-28 — Final status recorded
2022-11-29 — Assigned to examiner
2022-11-30 — Application abandoned
2022-11-30 — Application abandoned
Owner Information
Alembic Pharmaceuticals, Inc.
Bridgewater , NJ
Correspondent
ALBERT H MANWARING IV MORRIS JAMES LLP 500 DELAWARE AVENUE STE 1500 WILMINGTON, DE 19801
Filing Details
Filing Date:
2019-10-18
Status Date:
2022-11-28
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.